FDA Adverse Event Injury Summary report: N

EVERPATCH

MDR report key: 23052078 · Received September 15, 2025

Report

Report Number
3029772936-2025-00006
Event Type
Injury
Date Received
September 15, 2025
Date of Event
December 10, 2024
Report Date
September 15, 2025
Manufacturer
CORNEAT VISION, LTD.
Product Code
QWU
UDI-DI
G16010362950
PMA / PMN Number
K223074
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SC, US
Reporter Occupation
NURSE
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE DEVICE HISTORY RECORDS WERE REVIEWED FOR THIS MANUFACTURING LOT AND THERE WERE NO DISCREPANCIES OR UNUSUAL FINDINGS THAT RELATE TO THE REPORTED EVENT. THE IMPLANTED DEVICE WAS NOT AVAILABLE FOR EVALUATION. THE CURRENT DEVICE INSTRUCTIONS FOR USE IDENTIFIES THE FOLLOWING POSSIBLE COMPLICATIONS: "DETACHMENT OF THE DEVICE FROM SURROUNDING TISSUE IN CASE OF TRAUMA OR WHEN CHRONIC INFLAMMATION IS NOT ADDRESSED"; AND "CONJUNCTIVAL RETRACTION OR WOUND DEHISCENCE, WHICH MAY LEAD TO EXPOSURE OF THE DEVICE AND COULD REQUIRE A CORRECTIVE PROCEDURE". MANUFACTURER REFERENCE#: (B)(4).

Description of Event or Problem · 0

ON AUGUST 18, 2025, CORNEAT RECEIVED NOTIFICATION OF A CASE OF WOUND DEHISCENCE INVOLVING THE CORNEAT EVERPATCH. A PATIENT WITH A HISTORY OF CHRONIC ANGLE-CLOSURE GLAUCOMA UNDERWENT IMPLANTATION OF AN AHMED GLAUCOMA VALVE (AGV) ON (B)(6) 2024. THE PATIENT SUBSEQUENTLY REQUIRED AGV REVISION SURGERY ON (B)(6) 2024 FOR TUBE EXPOSURE, AT WHICH TIME THE AGV WAS COVERED WITH A CORNEAT EVERPATCH. APPROXIMATELY 4.5 MONTHS FOLLOWING IMPLANTATION OF CORNEAT EVERPATCH, THE CONJUNCTIVAL WOUND DEHISCED, AND THE CORNEAT EVERPATCH WAS PARTIALLY EXPOSED. THE PATIENT WAS TREATED WITH A TOPICAL ANTIBIOTIC. NO SURGICAL REVISION WAS PERFORMED. NO PERMANENT IMPAIRMENT, INCLUDING VISION LOSS, WAS OBSERVED DURING THE 18-MONTH POSTOPERATIVE PERIOD.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2506402 EVERPATCH PROSTHESIS, EYELID SPACER/GRAFT, POLYMER QWU CORNEAT VISION, LTD. 1007691 20230713 G16010362950

Patients

Seq Age Sex Outcome Treatment
1 69 YR Female Required Intervention AHMED GLAUCOMA VALVE (REVISION).